Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hainan Zicheng Zhongtou Biotechnology is a Chinese life sciences company focused on the development and clinical application of stem cell-based therapies. Located in the Boao Lecheng International Medical Tourism Pilot Zone, the company specializes in mesenchymal stem cell (MSC) research, including umbilical cord and adipose-derived cells. Its operations include a comprehensive stem cell bank, R&D laboratories, and clinical facilities dedicated to regenerative medicine. The company targets a variety of conditions such as knee osteoarthritis, spinal cord injuries, and metabolic diseases. It leverages the unique regulatory environment of Hainan to accelerate the translation of cell therapies into clinical practice. The company also provides medical tourism services centered around advanced cell-based treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hainan Zicheng Zhongtou Biotechnology.